Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

T2 Biosystems Q3 2024 GAAP EPS $(0.57) Beats $(0.64) Estimate, Sales $1.985M Miss $2.800M Estimate

Author: Benzinga Newsdesk | November 14, 2024 05:00pm
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.64) by 10.94 percent. The company reported quarterly sales of $1.985 million which missed the analyst consensus estimate of $2.800 million by 29.11 percent. This is a 34.85 percent increase over sales of $1.472 million the same period last year.

Posted In: TTOO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist